International Dividend ETF (DWX) Hits New 52-Week High

DWX

For investors looking for momentum, SPDR S&P International Dividend ETF (DWX - Free Report) is probably a suitable pick. The fund just hit a 52-week high — up roughly 18.2% from its 52-week low of $33.89/share.

Does it have more gains in store? Let’s take a look at the fund and its near-term outlook to gain an insight into where it might be headed:

DWX in Focus

The underlying S&P International Dividend Opportunities Index measures the performance of 100 highest dividend-yielding common stocks and ADRs listed in primary exchanges of countries included in the S&P Global BMI ex U.S.

The fund is heavily invested in sectors like financials (24.52%), utilities (20.51%), real estate (18.10%) and communication services (11.82%). Canada and Japan have double-digit weights in the fund. It charges 45 bps in fees (see all World ETFs here).

Why the Move?

Incessant cheap money inflows amid global policy easing are pushing stocks higher. A few upbeat earnings and trade optimism have been propelling the stocks higher.

More Gains Ahead?

The fund also has a positive weighted alpha of 10.90, which gives cues of further rally.

Want key ETF info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free>>

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>